Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
18 August 2021 | Story ANDRÉ DAMONS | Photo ANDRÉ DAMONS
Dr Osayande Evbuomwan, a Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, always wanted to specialise in an area of medicine that was novel, innovative, intriguing and involved a lot of opportunities for groundbreaking research

Dr Osayande Evbuomwan, Senior Lecturer and Medical Specialist in the Department of Nuclear Medicine, Faculty of Health Sciences, at the University of the Free State (UFS) always wanted to specialize in an area of medicine that was novel, innovative, intriguing and involved many opportunities for groundbreaking research.

This passionate medical man, who joined the UFS in 2019, is behind his department using Lutetium 177 PSMA (Lu-177 PSMA) therapy to treatment metastatic castrate resistant prostate cancer (MCRPC) – an advanced stage prostate cancer. 
The UFS and the Free State province can now join other South African universities, like the University of Pretoria, University of the Witwatersrand, and other provinces in using this method to treat MCRPC patients. 

Built for this job

Dr Evbuomwan explains nuclear medicine is a medical specialty that involves the use of unsealed sources of radiation in the form of radioisotopes for the diagnosis and treatment of various disease conditions including cancers.
“It’s novelty and opportunity for research and ability to diagnose and treat disease conditions in one specialty attracted me to this field. I always wanted to be a doctor. I see it as a calling. It was also something my mum discovered while I was growing up as a child. In my next life, I would choose to be a medical doctor again,” he says.

“I was built for this job and it is always my joy to have the opportunity to carry out my work. We have been well-trained for this; we support all our skills with prayers. We try to give our patients the very best,” says Dr Evbuomwan, who is originally from Benin City, Edo state, Nigeria. 

After graduating as a nuclear medicine specialist from Wits University, Dr Evbuomwan moved to the City of Roses after a work opportunity opened. He saw it as an opportunity to showcase his talents.

“I have been privileged to receive training in this treatment during my residency training at Wits. I treated a few of these patients during my training and the results were amazing. The University of Pretoria has also been involved with this treatment, with some amazing results that are recognised worldwide. 

“This was enough to convince me to push for our department to also join the powerhouses and offer this treatment to patients who need it. With the influence of a very understanding head of department, Dr Gerrit Engelbrecht, we have been successful in pushing for the commencement of this treatment at our facility,” says Dr Evbuomwan.

Important treatment
According to him, the availability and expertise of Lutetium 177 PSMA (Lu-177 PSMA) therapy to treat MCRPC is very important for the Free State and the UFS, as it is able to offer an option for patients who do not qualify for available conventional treatment and/or who have failed the first line of conventional treatment. 

“In the majority of patients this treatment offers improved quality of life, disease-free progression and improved overall survival. It also alleviates the constant bone pains these patients have to go through daily. To be able to offer this treatment puts the university and the province on the map alongside other top institutions in and outside the country. It also offers opportunity for research,” says Dr Evbuomwan.

He believes with a PET/CT camera for proper staging of these patients with cancer the UFS would be able to expand the treatment of patients suffering from this deadly illness. Currently the university does not possess such a camera and has to use lesser methods in identifying the right patients for this therapy.

News Archive

Enactus heeds call to be of service to its communities
2017-01-17

 Description: Enactus Tags: Enactus

The newly-elected vice president of Enactus
University of the Free State, Solomuzi Khati
(third from left) with members of Enactus on
the Qwaqwa Campus.
Photo: Thabo Kessah


The future of South Africa is in good hands if Enactus activities are anything to go by. Enactus is an international non-profit organisation bringing together student, academic and business leaders committed to using entrepreneurial action to improve lives. And the Qwaqwa Campus chapter is doing exactly that – changing lives.

Community engagement
This team of enthusiastic and energetic students have touched the Qwaqwa community in more ways than one through their community engagement activities. One such activity was when they adopted the Team Spirit Centre as their partner for development and empowerment.

“Up to now, the chapter has lived up to its purpose of assisting and uplifting the Qwaqwa community. As part of our programme, we identified a problem that we are currently helping to solve,” said Solomuzi Khati, the newly-elected vice president of Enactus University of the Free State.

Skills development
“We have realised that many centres housing orphaned and vulnerable children, like the Team Spirit in Makoane in Qwaqwa, are not sustainable. Our project introduced a business concept to the centre where we helped to plant vegetables so the owner Mrs Manthabeleng could then use and sell at a later stage,” he said. “In the process, students and Mrs Manthabeleng would develop various entrepreneurial, finance and business skills for future use on top of the centre generating income to sustain itself,” he added.

Appointment of Advisory Board
Khati also revealed Enactus was in the process of inviting business and community leaders into their Business Advisory Board. “This is a group of business people who are recruited to serve as mentors for our team. Typically, a Business Advisory Board is composed of 10-50 business leaders in the community. Board members can keep students informed of current business concerns and trends, provide financial or in-kind assistance for projects, critique annual reports and presentations, and provide networking opportunities.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept